Carisma Therapeutics Inc. Quarterly Common Stock, Shares, Issued from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Carisma Therapeutics Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q3 2024.
  • Carisma Therapeutics Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 41.8M shares, a 3.59% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 41.8M +1.45M +3.59% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 41.5M +1.28M +3.17% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 41.5M +1.29M +3.2% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 40.6M +38.4M +1731% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 40.3M -162M -80.1% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 40.3M -159M -79.8% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 40.3M -159M -79.8% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 2.22M -197M -98.9% Dec 31, 2022 10-K 2024-04-01
Q3 2022 203M +3.29M +1.65% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 199M +11M +5.84% Jun 30, 2022 10-Q/A 2022-08-25
Q1 2022 199M +27.5M +16% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 199M +59M +42% Dec 31, 2021 10-K 2023-02-28
Q3 2021 199M +75.8M +61.3% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 188M +71.8M +61.6% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 172M +62M +56.4% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 140M +33.6M +31.5% Dec 31, 2020 10-K 2022-02-28
Q3 2020 124M +22.4M +22.1% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 117M +15.4M +15.2% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 110M +32.5M +42% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 107M +29.3M +37.9% Dec 31, 2019 10-K 2021-03-15
Q3 2019 101M +24.2M +31.4% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 101M +24.3M +31.5% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 77.5M +34.4M +79.7% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 77.5M +42.8M +123% Dec 31, 2018 10-K 2020-03-16
Q3 2018 77.1M +52.4M +212% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 77M -24.6B Jun 30, 2018 10-Q 2018-08-14
Q1 2018 43.1M +18.4M +74.6% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 34.7M +10.2M +41.5% Dec 31, 2017 10-K 2019-03-01
Q3 2017 24.7M +543K +2.25% Sep 30, 2017 10-Q 2017-11-17
Q2 2017 24.7B* +24.7B Jun 30, 2017 10-Q 2017-08-14
Q1 2017 24.7M +4.92M +24.9% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 24.5M +4.91M +25% Dec 31, 2016 10-K 2018-04-02
Q3 2016 24.2M +4.62M +23.6% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 20M +698K +3.61% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 19.8M +1.75M +9.73% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 19.6M +1.69M +9.4% Dec 31, 2015 10-K 2017-03-24
Q3 2015 19.5M +3.4M +21.1% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 19.3M +3.22M +20% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 18M +1.98M +12.3% Mar 31, 2015 10-Q 2015-04-30
Q4 2014 17.9M +16.3M +996% Dec 31, 2014 10-K 2016-03-25
Q3 2014 16.1M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 16.1M Jun 30, 2014 10-Q 2014-08-13
Q1 2014 16M Mar 31, 2014 10-Q 2014-05-15
Q4 2013 1.64M Dec 31, 2013 10-K 2015-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.